Skip to main content
Uromedica's continence therapy system wins CMS reimbursement

The CMS has issued a reimbursement code to Uromedica for its ProACT Adjustable Continence Therapy for Men, a system indicated for the treatment of adult men with stress incontinence caused by post-surgical intrinsic sphincter deficiency that lasts for at least 12 months and has not responded to conservative therapy. The system has already been launched by the company in the US.

Full Story: